ライフサイエンスコーパス: Wellcome Trust

1 l, Department for International Development, Wellcome Trust).

2 ational Institutes of Health, Royal Society, Wellcome Trust.

3 search Cambridge Biomedical Research Centre; Wellcome Trust.

4 ses, EU 7th framework program PREDEMICS. and Wellcome Trust.

5 sion, Medical Research Council (UK), and the Wellcome Trust.

6 UK Department for International Development, Wellcome Trust.

7 ealth, Pan American Health Organization, and Wellcome Trust.

8 Council for Prevention of Blindness and the Wellcome Trust.

9 European Union Seventh Framework Programme, Wellcome Trust.

10 utes of Health, UK Medical Research Council, Wellcome Trust.

11 ), the European Union's HRES grants, and the Wellcome Trust.

12 National Institute for Health Research, and Wellcome Trust.

13 alth Research, British Heart Foundation, and Wellcome Trust.

14 European Commission and the Wellcome Trust.

15 Medical Research Council and the Wellcome Trust.

16 n Greater Mekong Sub-region cluster, and the Wellcome Trust.

17 evelopment, Global Challenges Research Fund, Wellcome Trust.

18 search Unit for Evaluation of Interventions, Wellcome Trust.

19 UK Department of Health and Wellcome Trust.

20 sconsin Network for Health Research, and the Wellcome Trust.

21 from the Research Councils UK (RCUK) and the Wellcome Trust.

22 epartment for International Development, and Wellcome Trust.

23 y Program "NeuroRehab" University of Zurich, Wellcome Trust.

24 UK Department for International Development, Wellcome Trust.

25 epartment for International Development, and Wellcome Trust.

26 UK Medical Research Council and Wellcome Trust.

27 US National Institutes of Health and Wellcome Trust.

28 Gavi, The Vaccine Alliance and Wellcome Trust.

29 utes of Health and Medical Research Council, Wellcome Trust.

30 arch Council, European Research Council, and Wellcome Trust.

31 Medical Research Council, Wellcome Trust.

32 British Heart Foundation, Wellcome Trust.

33 National Institute of Health Research; Wellcome Trust.

34 CONICYT of the Chilean government and the Wellcome Trust.

35 Department of Health and Social Care and The Wellcome Trust.

36 tes Foundation, SA Medical Research Council, Wellcome Trust.

37 UK Department of Health and the Wellcome Trust.

38 British Heart Foundation and Wellcome Trust.

39 axoSmithKline, Medical Research Council, and Wellcome Trust.

40 d the NIHR BRC at University College London, Wellcome Trust.

41 Bill & Melinda Gates Foundation and the Wellcome Trust.

42 epartment for International Development, and Wellcome Trust.

43 tment for International-Development, and the Wellcome Trust.

44 , Scobie and Claire Mackinnon Trust, and the Wellcome Trust.

45 epartment for International Development, and Wellcome Trust.

46 tion, Partnership for Child Development, and Wellcome Trust.

47 epartment for International Development, and Wellcome Trust.

48 Wellcome Trust, Addenbrooke's Charitable Trust, Raymond

49 Wellcome Trust, Ammalife, and National Institute for Hea

50 Wellcome Trust and amfAR (American Foundation for AIDS R

51 Wellcome Trust and Bill & Melinda Gates Foundation.

52 Wellcome Trust and Gavi, the Vaccine Alliance.

53 Wellcome Trust and Li Ka Shing Foundation.

54 Wellcome Trust and MRC Tropical Epidemiology Group.

55 The Wellcome Trust and Oxford Radcliffe Hospitals Biomedical

56 The Wellcome Trust and the Bill & Melinda Gates Foundation t

57 The Wellcome Trust and The Bill & Melinda Gates Foundation.

58 Wellcome Trust and the Bill & Melinda Gates Foundation.

59 h to clinical trials, in November, 2014, the Wellcome Trust and the Center for Infectious Disease Res

60 Wellcome Trust and the DELTAS Africa Initiative.

61 st 10 000 cases (a collaboration between the Wellcome Trust and the international MS Genetics Consort

62 , a parallel funding partnership between the Wellcome Trust and the UK Department of Health.

63 According to the Wellcome Trust and UK research councils' Common Principl

64 l Medicine, Pfizer, UK Department of Health, Wellcome Trust, and Bill & Melinda Gates Foundation (WOM

65 l, Royal Australasian College of Physicians, Wellcome Trust, and Bill & Melinda Gates Foundation.

66 search Cambridge Biomedical Research Centre, Wellcome Trust, and European Foundation for the Study of

67 t, UK National Institute of Health Research, Wellcome Trust, and Genesis Research Trust.

68 US Food and Drug Administration, Wellcome Trust, and German Research Council.

69 ational Natural Science Foundation of China, Wellcome Trust, and Kadoorie Charitable Foundation.

70 The Bill & Melinda Gates Foundation, the Wellcome Trust, and Medecins Sans Fronteres.

71 National Institute for Health Research, Wellcome Trust, and Medical Research Council.

72 02), Aeras, Bill & Melinda Gates Foundation, Wellcome Trust, and Oxford-Emergent Tuberculosis Consort

73 Imperial College Biomedical Research Centre, Wellcome Trust, and Rosetrees Trust.

74 epartment for International Development, the Wellcome Trust, and the Children's Investment Fund Found

75 Columbia Children's Hospital Foundation, the Wellcome Trust, and the Fleming Fund.

76 UK Medical Research Council, Wellcome Trust, and the UK Department for International

77 Bill & Melinda Gates Foundation, Wellcome Trust, and UK Department for International Deve

78 UK Medical Research Council, Wellcome Trust, and University of Bristol.

79 evelopment, Bill & Melinda Gates Foundation, Wellcome Trust, and Valent BioSciences LLC.

80 Bill & Melinda Gates Foundation, UNICEF, Wellcome Trust, Associacao Brasileira de Saude Coletiva.

81 ous Diseases, National Institutes of Health, Wellcome Trust, Bill & Melinda Gates Foundation, Medical

82 UK Department for International Development, Wellcome Trust, Bill & Melinda Gates Foundation, Medical

83 UK Department for International Development, Wellcome Trust, Bill & Melinda Gates Foundation, UK Medi

84 Wellcome Trust, Bill & Melinda Gates Foundation, UK Medi

85 Wellcome Trust, Bill & Melinda Gates Foundation, UK Medi

86 UK Medical Research Council, Wellcome Trust, Biotechnology and Biological Sciences Re

87 We applied our method to the Wellcome Trust bipolar disorder data and found a signifi

88 cal Research Council, Dementias Platform UK, Wellcome Trust, Brain Research UK, Wolfson Foundation, W

89 e for Health Research, Department of Health, Wellcome Trust, British Colombia Centre for Disease Cont

90 UK Medical Research Council, Wellcome Trust, British Heart Foundation, and AFA Insura

91 e, the present standard of care) at the NIHR/Wellcome Trust Cambridge Clinical Research Facility (Cam

92 cine Centre, Else Kroner Fresenius Stiftung, Wellcome Trust, Cancer Research UK, AstraZeneca UK, Univ

93 LUP to genome-wide association data from the Wellcome Trust Case Control Consortium (seven diseases),

94 using Affymetrix SNP genotype data from the Wellcome Trust Case Control Consortium (WTCCC) and uncov

95 od to seven case-control phenotypes from the Wellcome Trust Case Control Consortium (WTCCC) data and

96 from limited published associations from the Wellcome Trust Case Control Consortium (WTCCC) dataset.

97 nic basis of seven common diseases using the Wellcome Trust Case Control Consortium (WTCCC) GWAS resu

98 In a concurrent study, the Wellcome Trust Case Control Consortium (WTCCC) has repor

99 The Wellcome Trust Case Control Consortium (WTCCC) identifie

100 In 2007, the Wellcome Trust Case Control Consortium (WTCCC) performed

101 sociated with coronary artery disease in the Wellcome Trust Case Control Consortium (WTCCC) study (wh

102 riant RA association signals observed in the Wellcome Trust Case Control Consortium (WTCCC) study and

103 We have validated our method in the Wellcome Trust Case Control Consortium (WTCCC) study of

104 hesis, we applied linear mixed models to the Wellcome Trust Case Control Consortium (WTCCC) T2D data

105 ssociation with type 2 diabetes (T2D) in the Wellcome Trust Case Control Consortium (WTCCC) T2D GWAS.

106 predictive model for the KCNJ11 gene to the Wellcome Trust Case Control Consortium (WTCCC) Type 2 di

107 idual level genotype data generated from the Wellcome Trust Case Control Consortium (WTCCC) type 2 di

108 g genetic data from 4,500 individuals in the Wellcome Trust Case Control Consortium (WTCCC), case-con

109 ith CAD risk polymorphisms identified by the Wellcome Trust Case Control Consortium (WTCCC).

110 /C5 loci with RA using imputed data from the Wellcome Trust Case Control Consortium (WTCCC).

111 5619 unscreened controls from phase 2 of the Wellcome Trust Case Control Consortium (WTCCC2).

112 kb), rare copy-number variants (CNVs) in the Wellcome Trust Case Control Consortium 2 (WTCCC2) schizo

113 orks, and we tested it on data sets from the Wellcome Trust Case Control Consortium 2 (WTCCC2), the G

114 re than 5,000 Kenyan children as part of the Wellcome Trust Case Control Consortium 2 (WTCCC2).

115 netics, Archiving and Monograph (MORGAM) and Wellcome Trust Case Control Consortium 2 collections.

116 In a Wellcome Trust Case Control Consortium 2 multiple sclero

117 case-control Parkinson's disease studies (UK Wellcome Trust Case Control Consortium 2, Dutch Parkinso

118 ollected from the BMES cohort as part of the Wellcome Trust Case Control Consortium 2.

119 the Genetic Consortium for AN (GCAN) and the Wellcome Trust Case Control Consortium 3 (WTCCC3).

120 5,163 UK population controls as part of the Wellcome Trust Case Control Consortium 3 (WTCCC3).

121 nd 6015 control individuals (provided by the Wellcome Trust Case Control Consortium and KORA-gen) for

122 ndylitis (AS) was recently identified by the Wellcome Trust Case Control Consortium and the Australo-

123 ply our method to the seven studies from the Wellcome Trust Case Control Consortium and the major dep

124 ent Program for Bipolar Disorder cohort, the Wellcome Trust Case Control Consortium bipolar cohort, a

125 In the Wellcome Trust Case Control Consortium bipolar disorder

126 tion of our framework to the analysis of the Wellcome Trust Case Control Consortium data.

127 lable Affymetrix 500K genotype data from the Wellcome Trust Case Control Consortium for 1,868 BP case

128 iation (GWA) studies were available from the Wellcome Trust Case Control Consortium for 566 anti-TNF-

129 Using SNP data from the Wellcome Trust Case Control Consortium genome-wide assoc

130 We reanalyzed data from the Wellcome Trust Case Control Consortium genome-wide assoc

131 in the case-control samples genotyped by the Wellcome Trust Case Control Consortium study and imputed

132 We compared Indians with Europeans from the Wellcome Trust Case Control Consortium study; T1D (n = 1

133 ion studies based on the HapMap data and the Wellcome Trust Case Control Consortium to demonstrate th

134 We employed genome-wide data from the Wellcome Trust Case Control Consortium to test this hypo

135 tation in 3,004 additional controls from the Wellcome Trust Case Control Consortium was also performe

136 On the benchmark disease, datasets from The Wellcome Trust Case Control Consortium, RAPID ran in abo

137 nd 2938 population controls generated by the Wellcome Trust Case Control Consortium, we set out to de

138 t and National Blood Service cohort from the Wellcome Trust Case Control Consortium.

139 three autoimmune diseases from the original Wellcome Trust Case Control Consortium.

140 d on the first seven diseases studied by the Wellcome Trust Case Control Consortium.

141 th Cohort and seven common diseases from the Wellcome Trust Case Control Consortium.

142 and two shared control sets provided by the Wellcome Trust Case Control Consortium.

143 controls in the UK who were genotyped by the Wellcome Trust Case Control Consortium.

144 were accessed from the data generated by the Wellcome Trust Case Control Consortium.

145 nsively on three data sets obtained from the Wellcome Trust Case Control Consortium: type two diabete

146 ion for rare, recent variants in the outbred Wellcome Trust Case-Control Consortium (WTCCC) data.

147 es of the GWASelect are illustrated with the Wellcome Trust Case-Control Consortium (WTCCC) data.

148 y a powerful genetic mapping approach to the Wellcome Trust Case-Control Consortium and the National

149 The method was applied to the Wellcome Trust Case-Control Consortium Crohn disease (CD

150 An illustration involving the Wellcome Trust Case-Control Consortium data shows severa

151 in five novel loci also had P < 0.05 in the Wellcome Trust Case-Control Consortium dataset and were

152 consistency of this result with one from the Wellcome Trust Case-Control Consortium encourages furthe

153 Finally, SLINGER application on seven Wellcome Trust Case-Control Consortium genome-wide assoc

154 itish Birth Cohort and were genotyped by the Wellcome Trust Case-Control Consortium with the Illumina

155 by the whole-genome association study of the Wellcome Trust Case-Control Consortium, a parallel indep

156 e type 1 diabetes GWAS data collected by the Wellcome Trust Case-Control Consortium.

157 aritable Foundation, Imperial College London Wellcome Trust Centre for Global Health Research, and Ri

158 UK Department for International Development, Wellcome Trust, Children's Investment Fund Foundation, a

159 the University of Minnesota established the Wellcome Trust-CIDRAP Ebola Vaccine Team B initiative.

160 The Malawi Liverpool Wellcome Trust Clinical Research Programme (MLW) has rou

161 The Malawi-Liverpool-Wellcome Trust Clinical Research Programme has done sent

162 Wellcome Trust Clinical Research Training Fellowship.

163 al Institute on Aging (U24AG052175) and by a Wellcome Trust collaborative award (The Human Behaviour-

164 A report on the Wellcome Trust Conference on Computational RNA Biology,

165 tended OJIA (eOJIA) patients], and controls (Wellcome Trust control cohort, WTCCC2).

166 Medical Research Council, Wellcome Trust, Coordenacao de Aperfeicoamento de Pessoa

167 ociation analysis with improved power on the Wellcome Trust data consisting of seven common phenotype

168 On Wellcome Trust data for 15,000 individuals, FaST-LMM ran

169 Wellcome Trust, DELTAS Africa Initiative.

170 Wellcome Trust, Department for International Development

171 ian Department of Foreign Affairs and Trade, Wellcome Trust, Department of Science and Technology and

172 Sciences, Health Foundation, EU, ERC, NIHR, Wellcome Trust, Dutch Cancer Society, Dutch Digestive Fo

173 Medical Research Council, Wellcome Trust, Economic and Social Research Council, an

174 Wellcome Trust/EPSRC Centre for Medical Engineering, Nat

175 ancer Research, UK Medical Research Council, Wellcome Trust, EU Framework Cancer Pathways.

176 K MRC, Dinosaur Trust, NIH/NHLBI, ERS, EMBO, Wellcome Trust, EU, AHA, ACClinPharm, Netherlands CVRI,

177 Saudi Arabian Ministry of Health, Wellcome Trust, European Community, and National Institu

178 Gavi, the Vaccine Alliance, Wellcome Trust, European Society for Paediatric Infectio

179 Wellcome Trust, European Union, Medical Research Council

180 A report of the Wellcome Trust Functional Genomics and Systems Biology C

181 Disease (MND) Association, together with The Wellcome Trust, funded the creation of a national DNA Ba

182 Arthritis Research UK, Wellcome Trust, George Koukis Foundation, European Commu

183 Royal Society, Wellcome Trust, Global Challenges Research Fund (UK Rese

184 Wellcome Trust, Global Challenges Research Fund, and Hea

185 d Infectious Diseases, Grant R01AI051355 and Wellcome Trust, Grant 078332.

186 Ka Shing Oxford Global Health Programme and Wellcome Trust, Harvard Center for Communicable Disease

187 UK Department for International Development, Wellcome Trust, Health Data Research UK, Medical Researc

188 Wellcome Trust, Health Metrics Network (WHO).

189 Translational Infection Research Initiative, Wellcome Trust, Health Protection Agency, and the Nation

190 cil, National Institute for Health Research, Wellcome Trust, Heart Foundation Australia.

191 Common Diseases meeting co-sponsored by the Wellcome Trust, held at the Wellcome Trust Hinxton Confe

192 MRC, DfID, Wellcome Trust, Hewlett Foundation.

193 sponsored by the Wellcome Trust, held at the Wellcome Trust Hinxton Conference Centre July 7-10, 2007

194 uman fetal gut samples (obtained via the MRC-Wellcome Trust Human Developmental Biology Resource-UK)

195 Two meetings, one sponsored by the Wellcome Trust in 2012 and the other by the Global Virol

196 HB was supported by a Wellcome Trust Institutional Strategic Support Fund (via

197 Wellcome Trust Institutional Strategic Support Fund gran

198 Society for Endocrinology, Wellcome Trust Institutional Strategic Support Fund.

199 for Preventive Medicine (to R.C. May), and a Wellcome Trust Intermediate fellowship (089966, to T. Bi

200 Wellcome Trust Intermediate Fellowship to SRI, Fulbright

201 Wellcome Trust-Mahidol University-Oxford Tropical Medici

202 Department of Health of South Africa, the Wellcome Trust, Medecins Sans Frontieres, European and D

203 Wellcome Trust, Medical Research Council UK, Department

204 National Council of Science and Technology, Wellcome Trust, Medical Research Council, and Kidney Res

205 Wellcome Trust, Medical Research Council, and National I

206 Wellcome Trust, Medical Research Council, and UK Nationa

207 Wellcome Trust, Medical Research Council, British Heart

208 Wellcome Trust, Medical Research Council, British Heart

209 Wellcome Trust, Medical Research Council, Department of

210 Wellcome Trust, Medical Research Council, Economic and S

211 In October 2017, Malawi-Liverpool Wellcome Trust (MLW) organized a wide range of community

212 Wellcome Trust, MRC, BHF, CR-UK, Kadoorie Charitable Fou

213 UK Medical Research Council, Wellcome Trust, National Institute for Health Research O

214 Wellcome Trust, National Institute for Health Research S

215 Wellcome Trust, National Institute for Health Research,

216 Wellcome Trust, National Institute for Health Research,

217 Wellcome Trust, National Institute for Health Research,

218 Medical Research Council, Wellcome Trust, National Institute for Health Research,

219 Wellcome Trust, National Institute for Health Research.

220 NCT02755948.FUNDINGMedical Research Council, Wellcome Trust, National Institute for Health Research.

221 Wellcome Trust, National Institute for Health Service Su

222 Wellcome Trust, National Institute of Health Research, a

223 Wellcome Trust, National Institute of Health Research, M

224 Wellcome Trust, NIHR Cambridge Biomedical Research Centr

225 Wellcome Trust, NIHR Cambridge Biomedical Research Centr

226 Wellcome Trust, NIHR Oxford Biomedical Research Centre,

227 Gavi, The Vaccine Alliance and The Wellcome Trust of Great Britain.

228 Wellcome Trust, Oxford University Hospitals Research Ser

229 Wellcome Trust, Pan American Health Organization.

230 The Wellcome Trust, Papworth Hospital, NIHR Cambridge Biomed

231 UK Medical Research Council, UK Wellcome Trust, Parkinson's UK, Patrick Berthoud Trust,

232 Leading funding sources were the Wellcome Trust ( pound688 million, 26.4%) and the Medica

233 Meningitis Research Foundation, Wellcome Trust, Public Health England, European Union.

234 bridge and UCLH Biomedical Research Centres, Wellcome Trust, Raymond and Beverly Sackler Foundation,

235 This study was done at the KEMRI-Wellcome Trust Research Programme among residents of the

236 tion Society (fellowship to T. Bicanic), the Wellcome Trust (research training fellowships WT069991,

237 In the Wellcome Trust Rheumatoid Arthritis study, STAMS-identif

238 , UK National Institute for Health Research, Wellcome Trust, Rosetrees Trust, Stoneygate Trust.

239 Wellcome Trust, Sackler Fund, National Instititute for H

240 of the collaboration, who are from NCBI, the Wellcome Trust Sanger Institute and the University of Ca

241 Here we describe the Wellcome Trust Sanger Institute Genome Editing database

242 rate (FDR) of the cleanest dataset from the Wellcome Trust Sanger Institute is 12.5%.

243 The Wellcome Trust Sanger Institute is one of the world's la

244 roughput mouse phenotyping data set from the Wellcome Trust Sanger Institute Mouse Genetics Project,

245 in SPRET/Ei from the Mouse Genomes Project (Wellcome Trust Sanger Institute) and processed these dat

246 ena Dolman's second affiliation was given as Wellcome Trust Sanger Institute, Wellcome Genome Campus,

247 erated by the Pathogen Genomics group at the Wellcome Trust Sanger Institute.

248 SMIC), a large-scale database curated by the Wellcome Trust Sanger Institute.

249 zebrafish genomic sequences produced at the Wellcome Trust Sanger Institute.

250 diovascular Disease in Russia supported by a Wellcome Trust Strategic Award (100217) and was supporte

251 This work was supported by the Wellcome Trust Strategic Award for Medical Mycology and

252 Wellcome Trust, Swedish Research Council, and Swedish Re

253 Wellcome Trust, Swedish Research Council, and the Swedis

254 UK Department for International Development, Wellcome Trust, Swiss Development Cooperation, UNICEF, a

255 Bill & Melinda Gates Foundation, UK Aid, Wellcome Trust, Swiss Development Cooperation, US Nation

256 Wellcome Trust, the Bill & Melinda Gates Foundation, and

257 ealth, the CIHR (Canada), the NIHR (UK), the Wellcome Trust, the Henry Smith Charity, and Action Medi

258 Wellcome Trust, the National Institute of Health Researc

259 sical Sciences Research Council (EPSRC), The Wellcome Trust, the National Institute of Health Researc

260 r Health Research, Medical Research Council, Wellcome Trust, The Scottish Government (RESAS).

261 The Wellcome Trust, the Swedish Prison and Probation Service

262 Wellcome Trust, the Swedish Prison and Probation Service

263 Wellcome Trust, the Swedish Research Council, and the Sw

264 WHO, UK Wellcome Trust, the UK Government through the Department

265 Wellcome Trust, the World Bank through the Partnership f

266 and Fred Hutch Center for AIDS Research; the Wellcome Trust; the University of Washington Royalty Res

267 ional Institute for Health Research, and the Wellcome Trust through the Joint Global Health Trials Sc

268 Wellcome Trust through the Scottish Translational and Th

269 uropean Union's Seventh Framework Programme, Wellcome Trust Translational Medicine & Therapeutics Pro

270 higher with STAMS than EW_dmGWAS run on the Wellcome Trust Type 1 Diabetes data.

271 of the GlaxoSmithKline group of companies), Wellcome Trust UK, Medical Research Council: Respiratory

272 Wellcome Trust (UK), Medical Research Council of South A

273 rch, National Institute for Health Research, Wellcome Trust (UK), Swedish Association of Local Author

274 WHO, with support from the Wellcome Trust (UK); Medecins Sans Frontieres; the Norwe

275 Bill & Melinda Gates Foundation, Wellcome Trust, UK Department for International Developm

276 Wellcome Trust, UK Medical Research Council (MRC), Austr

277 Wellcome Trust, UK Medical Research Council, Dunhill Med

278 Wellcome Trust, UK Medical Research Council, European Un

279 Wellcome Trust, UK Medical Research Council, Li Ka Shing

280 , Pfizer, GlaxoSmithKline, Servier, HemoCue, Wellcome Trust, UK Medical Research Council, UK National

281 ncil, Aarhus University Research Foundation, Wellcome Trust, UK Medical Research Council, UK NIHR Hea

282 Wellcome Trust, UK Ministry of Defence, and National Ins

283 Wellcome Trust, UK National Institute for Health Researc

284 Wellcome Trust, UK National Institute for Health Researc

285 zation, Sherman Foundation, NeMO Foundation, Wellcome Trust, UK National Institute for Health Researc

286 Wellcome Trust, UK, and Global Antibiotic Resistance Par

287 ters for Disease Control and Prevention; and Wellcome Trust, UK.

288 ion Research; Baily Thomas Charitable Trust; Wellcome Trust; UK Medical Research Council; European Un

289 UK Department for International Development, Wellcome Trust, US National Institutes of Health, Royal

290 Wellcome Trust via an Edinburgh Clinical Academic Traini

291 National Institute for Health Research, Wellcome Trust, WHO, US Alzheimer's Association, and Eur

292 from the UK Medical Research Council and the Wellcome Trust, with support from the Economic and Socia

293 from the UK Medical Research Council and the Wellcome Trust, with support from the Economic and Socia

294 Wellcome Trust, Wolfson Foundation, British Heart Founda

295 Wellcome Trust, Wolfson Foundation, British Heart Founda

296 Wellcome Trust, Wolfson Foundation, UK Medical Research

297 for Health, Welfare, and Family Affairs, UK Wellcome Trust, Wolfson Foundation, UK Stroke Associatio

298 Wellcome Trust, Wolfson Foundation, UK Stroke Associatio

299 SPARCLE2 was funded by: Wellcome Trust WT086315 A1A (UK and Ireland); Medical Fa

300 s work was made possible by funding from the Wellcome Trust (WT088148MF), the Medical Research Counci